(R)-2-Methylpyrrolidine-2-carboxylic acid hydrochloride

Catalog No. :
ACEMYW154
CAS No. :
123053-48-5
Molecular Formula :
C6H12ClNO2
Molecular Weight :
165.62

IUPAC Name:(R)-2-methylpyrrolidine-2-carboxylic acid hydrochloride

(R)-2-Methylpyrrolidine-2-carboxylic acid hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g98%$75.00Login to see priceIn stockInquiry
25g98%$150.00Login to see priceIn stockInquiry
100g98%$413.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-2-Methylpyrrolidine-2-carboxylic acid hydrochloride
IUPAC Name(R)-2-methylpyrrolidine-2-carboxylic acid hydrochloride
MDL No.MFCD20487714
Molecular FormulaC6H12ClNO2
Molecular Weight165.62
SMILESO=C([C@]1(C)NCCC1)O.[H]Cl
InChI KeyYWPABDPNGQMUFH-FYZOBXCZSA-N
Synonym123053-48-5 | (R)-2-Methylpyrrolidine-2-carboxylic acid hydrochloride | 2-METHYL-D-PROLINE HYDROCHLORIDE | (2R)-2-methylpyrrolidine-2-carboxylic acid hydrochloride | D-PROLINE, 2-METHYL-, HYDROCHLORIDE | 2-Methyl-D-proline HCl | (2R)-2-methylpyrrolidine-2-carboxylic
CAS No.123053-48-5
PubChem CID71305270

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACEMYW154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEMYW154 route product structure diagram
    ACEMYW154123053-48-5 In Stock
Inquiry

2. ACEMYW154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACESQW870 route compound structure diagram
    ACESQW870166170-15-6 In Stock
  2. Then
  3. ACEMYW154 route product structure diagram
    ACEMYW154123053-48-5 In Stock
Inquiry

Comments (0)